1 - Research experience and ability
|
Quality
Management |
Training and
Education |
Public
Involvement |
| Description | |
|---|---|
Name |
FP-MCRN - Family Pediatricians Medicines for Children Research Network) |
| Number of completed trials | 1 |
| Number of ongoing trials | 1 |
| Total number of participants actually recruited each year | 4200 |
| Proportion of eligible participants actually recruited each year | 3400 |
| Describe way of screening and participant recruitment | The FP-MCRN can survey more than 6.000.000 Italian children.The merit of FP is their close elective involvement with children and their families. In Italy, a FP generally establishes a very strong and close “pediatrician-parents” and “pediatrician-child” relationship. For this reason it become easier the capacity to assess and involve outpatients in clinical trials. Practical reasons:1) Numbers of patients;2)FP as a member of the family;3) Direct relationship with the children;4) Presence of territorial pathologies;5) Frequency of the contacts out-patient both in ambulatory and domiciliary : Importance of the family communication. 1)Explain in simple way, easily comprehensible and with sincerity; 2)Reassurance on:importance of the benefits,risks minimisation; experience of the pediatricians; the policy privacy;the protection of the data;3)Correct information and family consent ;4) Correct Information and Children Assent |
| Total number of collaborating centres | 3 |
| Academic investigator initiated studies | |
| Number of ongoing and completed clinical trials. Absolute number | 0 |
| Number of ongoing and completed clinical trials. Proportion of all studies | 100% |
| Number of paediatric specialties covered by paediatric trials] | 3 |
| Number of paediatric conditions covered by paediatric trials] | 3 |
| Number of other ongoing research studies programs] | 1 |
| Proportion of academic initiated studies | 100% of the budget derived from governmental programs (AIFA PhVG Call 2008-2009 and AIFA PHVG Call 2010-2011) AIFA |
| Proportion of budget | The budget handled for complete and ongoing trials is derived from FP-MCRN Onlus funding sources (AIFA Pharmacovigilance Call 2008-2009 and 2010-2011) |
| Number of registered study participants. All studies |
1 |
| Number of ongoing and completed trials | 2 |
| Number of paediatric specialties covered by paediatric trials | 3 |
| Number of paediatric conditions covered by paediatric trialss | 3 |
| Number of registered study participants all studies | 1 |